Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation
2011

Estrogen Receptor Beta's Role in Breast Cancer Gene Regulation

publication Evidence: high

Author Information

Author(s): Grober Oli MV, Mutarelli Margherita, Giurato Giorgio, Ravo Maria, Cicatiello Luigi, De Filippo Maria Rosaria, Ferraro Lorenzo, Nassa Giovanni, Papa Maria Francesca, Paris Ornella, Tarallo Roberta, Luo Shujun, Schroth Gary P, Benes Vladimir, Weisz Alessandro

Hypothesis

The study investigates how estrogen receptor beta (ERβ) interacts with estrogen receptor alpha (ERα) to regulate target genes in breast cancer cells.

Conclusion

The study concludes that ERβ's genomic targets often overlap with those of ERα, indicating that their combined action is crucial for gene regulation in hormone-responsive breast cancer cells.

Supporting Evidence

  • ERβ binding sites were identified in the genome of MCF-7 cells, showing extensive overlap with ERα binding sites.
  • Expression of ERβ in MCF-7 cells reduced cell proliferation in response to estrogen.
  • ChIP-Seq analysis revealed 9702 ERβ and 6024 ERα binding sites, with many genes regulated by both receptors.

Takeaway

This study shows that two proteins, ERα and ERβ, work together to control how breast cancer cells respond to estrogen, which is important for understanding cancer growth.

Methodology

The study used ChIP-Seq to identify binding sites of ERα and ERβ in breast cancer cells and analyzed gene expression changes in response to estrogen.

Limitations

The study may not account for all potential ERβ target genes due to the focus on early response genes and the specific cell line used.

Digital Object Identifier (DOI)

10.1186/1471-2164-12-36

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication